Tilak Mandadi, EVP, Chief Exp & Technology Officer at CVS HEALTH Corp (CVS), sold 69,551 shares at $89.58 ($6.2M) on 2026-05-08, disclosed to the SEC on 2026-05-11.
Open-market sale of $6.2M CVS by EVP, Chief Exp & Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.